Market Closed -
Borsa Istanbul
11:09:41 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
45.88
TRY
|
-2.42%
|
|
-1.97%
|
+87.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
46.2
|
78.54
|
378
|
258.7
|
1,342
|
1,029
|
Enterprise Value (EV)
1 |
139.7
|
241.4
|
566.1
|
550.7
|
1,806
|
1,922
|
P/E ratio
|
-2.39
x
|
-2.34
x
|
-14.1
x
|
-2.19
x
|
-9.97
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.2
x
|
0.35
x
|
1.49
x
|
0.76
x
|
1.74
x
|
1.11
x
|
EV / Revenue
|
0.61
x
|
1.08
x
|
2.24
x
|
1.62
x
|
2.35
x
|
2.08
x
|
EV / EBITDA
|
5.24
x
|
13.9
x
|
21.2
x
|
74.4
x
|
41.3
x
|
-10.9
x
|
EV / FCF
|
8.3
x
|
-5.21
x
|
-145
x
|
-53.9
x
|
-22.9
x
|
-5.68
x
|
FCF Yield
|
12%
|
-19.2%
|
-0.69%
|
-1.86%
|
-4.37%
|
-17.6%
|
Price to Book
|
1.67
x
|
16.2
x
|
-15.8
x
|
11.3
x
|
7.46
x
|
-
|
Nbr of stocks (in thousands)
|
42,000
|
42,000
|
42,000
|
42,000
|
42,000
|
42,000
|
Reference price
2 |
1.100
|
1.870
|
9.000
|
6.160
|
31.96
|
24.50
|
Announcement Date
|
3/1/19
|
3/2/20
|
2/26/21
|
3/1/22
|
3/1/23
|
5/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
230.2
|
224
|
252.9
|
340.1
|
770.2
|
926.2
|
EBITDA
1 |
26.67
|
17.4
|
26.74
|
7.405
|
43.78
|
-177
|
EBIT
1 |
19.46
|
8.507
|
16.99
|
-3.413
|
25.78
|
-236.8
|
Operating Margin
|
8.45%
|
3.8%
|
6.72%
|
-1%
|
3.35%
|
-25.57%
|
Earnings before Tax (EBT)
1 |
-18.97
|
-33.75
|
-26.31
|
-121.9
|
-132.1
|
-84.16
|
Net income
1 |
-19.34
|
-33.52
|
-26.78
|
-118.2
|
-134.7
|
-40.85
|
Net margin
|
-8.4%
|
-14.96%
|
-10.59%
|
-34.77%
|
-17.49%
|
-4.41%
|
EPS
2 |
-0.4604
|
-0.7982
|
-0.6377
|
-2.815
|
-3.207
|
-
|
Free Cash Flow
1 |
16.83
|
-46.3
|
-3.894
|
-10.22
|
-78.86
|
-338.2
|
FCF margin
|
7.31%
|
-20.66%
|
-1.54%
|
-3.01%
|
-10.24%
|
-36.52%
|
FCF Conversion (EBITDA)
|
63.09%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
3/2/20
|
2/26/21
|
3/1/22
|
3/1/23
|
5/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
93.5
|
163
|
188
|
292
|
464
|
893
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.505
x
|
9.359
x
|
7.036
x
|
39.43
x
|
10.59
x
|
-5.047
x
|
Free Cash Flow
1 |
16.8
|
-46.3
|
-3.89
|
-10.2
|
-78.9
|
-338
|
ROE (net income / shareholders' equity)
|
-61%
|
-206%
|
281%
|
22,035%
|
-133%
|
-18.9%
|
ROA (Net income/ Total Assets)
|
4.84%
|
1.93%
|
3.54%
|
-0.48%
|
1.87%
|
-10.7%
|
Assets
1 |
-399.5
|
-1,738
|
-756.3
|
24,779
|
-7,199
|
382.9
|
Book Value Per Share
2 |
0.6600
|
0.1200
|
-0.5700
|
0.5400
|
4.290
|
-
|
Cash Flow per Share
2 |
0.1500
|
0.1300
|
0.4700
|
0.4300
|
1.940
|
-
|
Capex
1 |
10.8
|
10.2
|
16.7
|
37.7
|
37
|
47.2
|
Capex / Sales
|
4.71%
|
4.53%
|
6.61%
|
11.1%
|
4.8%
|
5.1%
|
Announcement Date
|
3/1/19
|
3/2/20
|
2/26/21
|
3/1/22
|
3/1/23
|
5/8/24
|
|
1st Jan change
|
Capi.
|
---|
| +87.27% | 59.82M | | -2.59% | 18.77B | | -7.40% | 4.02B | | +3.08% | 3.61B | | +6.00% | 2.7B | | -20.30% | 1.44B | | +53.89% | 1.38B | | +13.60% | 926M | | +19.26% | 799M | | +22.64% | 431M |
Sanitary Products
|